Pfizer shares gain 5% on successful trial results for obesity drug
Positive mid-stage trial results for obesity drugPatients lost ten pounds in 16 weeksBig market opportunityShares in Pfizer (PFE:NYSE) gained over 5% in US trading last night after the company revealed a full-peer review of...
23 May 2023